Wiki diagnosis coding for biopsy

Community Wiki

This is a community-maintained wiki post containing the most important information from this thread. You may edit the Wiki once you have been on AAPC for 30 days and have made 5 posts. Learn More
G
Code: D48.5

Code Name: ICD-10 Code for Neoplasm of uncertain behavior of skin

Block: Neoplasms of uncertain behavior, polycythemia vera and myelodysplastic syndromes (D37-D48)

Excludes 1: neoplasms of unspecified behavior (D49.-)

Note: Categories D37-D44, and D48 classify by site neoplasms of uncertain behavior, i.e., histologic confirmation whether the neoplasm is malignant or benign cannot be made.

Details: Neoplasm of uncertain behavior of skin
Neoplasm of uncertain behavior of anal margin
Neoplasm of uncertain behavior of anal skin
Neoplasm of uncertain behavior of perianal skin
Neoplasm of uncertain behavior of skin of breast

Excludes 1: neoplasm of uncertain behavior of anus NOS (D37.8)
neoplasm of uncertain behavior of skin of genital organs (D39.8, D40.8)
neoplasm of uncertain behavior of vermilion border of lip (D37.0)
D48

Excludes1: neurofibromatosis (nonmalignant) (Q85.0-)

Guidelines: Neoplasms (C00-D49)

Note: Functional activity
All neoplasms are classified in this chapter, whether they are functionally active or not. An additional code from Chapter 4 may be used, to identify functional activity associated with any neoplasm.
Morphology [Histology]
Chapter 2 classifies neoplasms primarily by site (topography), with broad groupings for behavior, malignant, in situ, benign, etc. The Table of Neoplasms should be used to identify the correct topography code. In a few cases, such as for malignant melanoma and certain neuroendocrine tumors, the morphology (histologic type) is included in the category and codes.
Primary malignant neoplasms overlapping site boundaries
A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere. For multiple neoplasms of the same site that are not contiguous, such as tumors in different quadrants of the same breast, codes for each site should be assigned.
Malignant neoplasm of ectopic tissue
Malignant neoplasms of ectopic tissue are to be coded to the site mentioned, e.g., ectopic pancreatic malignant neoplasms are coded to pancreas, unspecified (C25.9).

For more details on D48.5, ICD-10 Code for Neoplasm of uncertain behavior of skin , visit: https://coder.aapc.com/icd-10-codes/

cgifford

Contributor
Messages
15
Best answers
0
Patient comes in and has a biopsy I was taught in class to wait until the Path is recd back to bill with the correct dx. The physician I work for states we should bill with d48.5, Neoplasm, uncertain behavior. Which is correct and what do you do? If anyone knows where I can find it in black and white to show that would be great.
 

mitchellde

True Blue
Messages
13,409
Location
Columbia, MO
Best answers
1
You cannot use D48.5 without a path report that indicates uncertain behavior. Look in your code book under the sub chapter heading for the D47-D48 section. I.e. Histologic confirmation of whether the neoplasm is malignant or benign cannot be made.
Histologic confirmation is a path report. You can use as a dx code the skin lesion. Look under lesion then skin and you get L98.9.
 

CatchTheWind

True Blue
Messages
617
Best answers
0
You can also use D49.2 "neoplasm of unspecified behavior." That's the more "technically correct" version of the more common "neoplasm of uncertain behavior." Both codes are used commonly for biopsies, and there is controversy about whether you need to use D49.2 rather than D48.5. The AAD says it's okay to use either one. I am not aware of any source that maintains that these codes should not be used for biopsies.
 
Last edited:

mitchellde

True Blue
Messages
13,409
Location
Columbia, MO
Best answers
1
The definition in the code book for these codes indicates that for uncertain behavior you need histologic confirmation and this a path report. For unspecified you need a preliminary dx of a tumor or new growth. It tells you the term "mass" (in quotes this means mass and other similar term like lump or lesion) is not to be regarded as a neoplasm unless otherwise documented by the provider. So for the biopsy which is a preliminary diagnostic study, you use what the provider documents as a lesion or mass.
 

mitchellde

True Blue
Messages
13,409
Location
Columbia, MO
Best answers
1
It is in evey code book that I have looked at. Look at the sub section for neoplasm of uncertain behavior and again at neoplasm unspecified.
Neoplasm of Uncertain Behavior (D37-D48)
Note: Categories D37- D48 classify by site neoplasms of uncertain behavior, i.e. histologic confirmation whether the neoplasm is malignant or benign cannot be made.
Neoplasms of unspecified behavior (D49)
Note: Category D49 classifies by site neoplasms of unspecified morphology and behavior. The term “mass”, unless otherwise stated, is not to be regarded as a neoplastic growth.
Includes: “growth” NOS
neoplasm NOS
new growth NOS
tumor NOS
In addition coding clinics stated that you would need to a preliminary diagnostic study interpretation to use unspecified. It is unspecified because without more definitive study the provider has no way to know benign, malignant or uncertain behavior. However from the preliminary study the provider has ruled out all other possible diagnoses.
 
Last edited:

CodingKing

True Blue
Messages
3,920
Best answers
0
Someone correct me if my thought are off base but I'm hoping i'm not the only one who is a little nervous about the fact there are physician that deals with skin cancer who don't know the difference between, Benign, Malignant and Uncertain behavior?
 

mitchellde

True Blue
Messages
13,409
Location
Columbia, MO
Best answers
1
No physician would know based on sight whether an abnormality is benign, malignant or uncertain behavior. It always take a histologic study via microscope to know the difference.
 

CodingKing

True Blue
Messages
3,920
Best answers
0
Debra, i was referring to not realizing Uncertain behavior is an actual status between benign, in-situ and malignant.
 

mitchellde

True Blue
Messages
13,409
Location
Columbia, MO
Best answers
1
Apologies and I agree. Although it may be due to misunderstanding of the code for uncertain behavior. Some coders as well as physicians have mistakenly interpret this to mean that the provider is uncertain as to what they are looking at. They do not realize that these codes were created to indicate patient diagnosis, not provider thoughts.
 

mitchellde

True Blue
Messages
13,409
Location
Columbia, MO
Best answers
1
if you are billing for the biopsy you must either bill the dx from the path report or use the L code for the skin lesion. without the path you do not have the diagnosis for the D48 code and without a preliminary study you will not have the documentation to support the D49. it is a skin lesion and that is what you can code.
 

CatchTheWind

True Blue
Messages
617
Best answers
0
If the biopsy is done on a lesion, then D49.2 is appropriate, since lesions are neoplasms and this is explicitly what the D49 section is to be used for.

The only time you would need to use a code from the L series (or wait for path, if you prefer) is if the biopsy is being done on something other than a lesion, such as a rash.
 
Top